This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Peroxiredoxin
From Proteopedia
| Line 5: | Line 5: | ||
'''Typical 2-Cys Prx'''<br /> | '''Typical 2-Cys Prx'''<br /> | ||
* '''Prx 1''' interacts with signaling molecules<ref>PMID:19923889</ref>. | * '''Prx 1''' interacts with signaling molecules<ref>PMID:19923889</ref>. | ||
| - | * '''Prx 2''' | + | * '''Prx 2''' is essential for sustaining erythrocyte life span<ref>PMID:18479207</ref>. |
| - | * '''Prx 3''' | + | * '''Prx 3''' is mitochondria-specific.<ref>PMID:15280382</ref>. |
| - | * '''Prx 4''' | + | * '''Prx 4''' localizes to the cytoplasm and regulates the activation of NF-κB<ref>PMID:25656995</ref>. |
'''Atypical 2-Cys Prx'''<br /> | '''Atypical 2-Cys Prx'''<br /> | ||
* '''Prx 5''' interacts with signaling molecules<ref>PMID:19923889</ref>. | * '''Prx 5''' interacts with signaling molecules<ref>PMID:19923889</ref>. | ||
| Line 14: | Line 14: | ||
== Relevance == | == Relevance == | ||
| - | Prx are over expressed in cancer tissue<ref>PMID:11497302</ref>. | + | Prx are over expressed in cancer tissue<ref>PMID:11497302</ref>. Prx 4 mediates osteoclast activation in cancer cells<ref>PMID:25779674</ref>. |
== 3D Structures of Peroxiredoxin == | == 3D Structures of Peroxiredoxin == | ||
Revision as of 10:35, 21 June 2016
Contents |
Function
Peroxiredoxin (Prx) is an antioxidant enzyme. In the Prxs the active-site Cys is oxidized to sulfenic acid byperoxide. The Prxs are divided into typical 2-Cys Prx, atypical 2-Cys Prx and 1-Cys Prx. Prx 5 is expressed in mammalian tissue.
Typical 2-Cys Prx
- Prx 1 interacts with signaling molecules[1].
- Prx 2 is essential for sustaining erythrocyte life span[2].
- Prx 3 is mitochondria-specific.[3].
- Prx 4 localizes to the cytoplasm and regulates the activation of NF-κB[4].
Atypical 2-Cys Prx
- Prx 5 interacts with signaling molecules[5].
1-Cys Prx
- Prx 6 interacts with signaling molecules[6].
Relevance
Prx are over expressed in cancer tissue[7]. Prx 4 mediates osteoclast activation in cancer cells[8].
3D Structures of Peroxiredoxin
Updated on 21-June-2016
References
- ↑ Neumann CA, Cao J, Manevich Y. Peroxiredoxin 1 and its role in cell signaling. Cell Cycle. 2009 Dec 15;8(24):4072-8. Epub 2009 Dec 5. PMID:19923889 doi:http://dx.doi.org/10.4161/cc.8.24.10242
- ↑ Low FM, Hampton MB, Winterbourn CC. Peroxiredoxin 2 and peroxide metabolism in the erythrocyte. Antioxid Redox Signal. 2008 Sep;10(9):1621-30. doi: 10.1089/ars.2008.2081. PMID:18479207 doi:http://dx.doi.org/10.1089/ars.2008.2081
- ↑ Chang TS, Cho CS, Park S, Yu S, Kang SW, Rhee SG. Peroxiredoxin III, a mitochondrion-specific peroxidase, regulates apoptotic signaling by mitochondria. J Biol Chem. 2004 Oct 1;279(40):41975-84. Epub 2004 Jul 27. PMID:15280382 doi:http://dx.doi.org/10.1074/jbc.M407707200
- ↑ Fujii J, Ikeda Y, Kurahashi T, Homma T. Physiological and pathological views of peroxiredoxin 4. Free Radic Biol Med. 2015 Jun;83:373-9. doi: 10.1016/j.freeradbiomed.2015.01.025., Epub 2015 Feb 2. PMID:25656995 doi:http://dx.doi.org/10.1016/j.freeradbiomed.2015.01.025
- ↑ Neumann CA, Cao J, Manevich Y. Peroxiredoxin 1 and its role in cell signaling. Cell Cycle. 2009 Dec 15;8(24):4072-8. Epub 2009 Dec 5. PMID:19923889 doi:http://dx.doi.org/10.4161/cc.8.24.10242
- ↑ Neumann CA, Cao J, Manevich Y. Peroxiredoxin 1 and its role in cell signaling. Cell Cycle. 2009 Dec 15;8(24):4072-8. Epub 2009 Dec 5. PMID:19923889 doi:http://dx.doi.org/10.4161/cc.8.24.10242
- ↑ Noh DY, Ahn SJ, Lee RA, Kim SW, Park IA, Chae HZ. Overexpression of peroxiredoxin in human breast cancer. Anticancer Res. 2001 May-Jun;21(3B):2085-90. PMID:11497302
- ↑ Rafiei S, Tiedemann K, Tabaries S, Siegel PM, Komarova SV. Peroxiredoxin 4: a novel secreted mediator of cancer induced osteoclastogenesis. Cancer Lett. 2015 Jun 1;361(2):262-70. doi: 10.1016/j.canlet.2015.03.012. Epub, 2015 Mar 14. PMID:25779674 doi:http://dx.doi.org/10.1016/j.canlet.2015.03.012
